Efficacy and Long-Term Safety of Everolimus in Pancreatic Neuroendocrine Tumor Associated with Multiple Endocrine Neoplasia Type I: Case Report

Publisher： Karger

E-ISSN： 2296-5262|39|10|643-645

ISSN： 2296-5270

Source： Oncology Research and Treatment, Vol.39, Iss.10, 2016-09, pp. : 643-645

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Long-Term Disease Control of a Pancreatic Neuroendocrine Tumor with Lanreotide Autogel®: A Case Report

By  

Case Reports in Oncology, Vol. 7, Iss. 3, 2014-09 ,pp. : 673-680

Karger

Access to resources Recommend Favorite

In vivo proton MR spectroscopy of pancreatic neuroendocrine tumors in a multiple endocrine neoplasia type 1 conditional knockout mouse model

By  

MAGNETIC RESONANCE IN MEDICINE, Vol. 74, Iss. 5, 2015-11 ,pp. : 1221-1226

John Wiley & Sons Inc

Access to resources Recommend Favorite

Treatment of Multiple Endocrine Neoplasia 1/2 Tumors: Case Report and Review of the Literature

By  

Oncology, Vol. 84, Iss. 3, 2012-12 ,pp. : 127-134

Karger

Access to resources Recommend Favorite

Ductulo‐insular pancreatic endocrine tumor with amyloid deposition: Report of a case

By  

PATHOLOGY INTERNATIONAL, Vol. 65, Iss. 4, 2015-04 ,pp. : 197-201

John Wiley & Sons Inc

Access to resources Recommend Favorite

Long-Term Efficacy of S-1 Chemotherapy plus Administration of Octreotide for a Patient with Metastatic Neuroendocrine Tumor (Gastrinoma)

By  

Case Reports in Oncology, Vol. 10, Iss. 2, 2017-05 ,pp. : 420-427

Karger

Access to resources Recommend Favorite